National Comprehensive Cancer Network

Educational Events & Programs

NCCN Clinical Practice Guidelines in Oncology Symposium™ Non-Small Cell Lung Cancer

Friday, November 13, 2009 (Palo Alto, California)

Register now to secure a seat at this symposium.

Program Overview:
Based on the deliberations of experts from 21 leading cancer centers, the NCCN Non-Small Cell Lung Cancer Guidelines provide sequential recommendations for the management of lung malignancies. This symposium will present these algorithms and focus on new approaches that have been incorporated into the guidelines, including the use of drugs, biologics, and diagnostics. The meeting format features case report presentations and audience feedback (via an audience response system) to highlight application of the guidelines in clinical practice. Participants are given the opportunity to comment on the guidelines with their developers and provide input for consideration in future updates.

Educational Objectives:
Following this program, participants should be able to:

• Describe the different surgical approaches to management based on site and stage at presentation and indications for surgery in non-small cell lung cancer
• Outline the principles of surgical resection in non-small cell lung cancer
• Describe the appropriate work-up for patients with non-small cell lung cancer
• State the role of pre- and post-operative radiation in combination with chemotherapy in the management of non-small cell lung cancer
• Describe the current status of neoadjuvant chemotherapy for Stage III non-small cell lung cancer
• Identify the roles of new therapies in new management strategies for metastatic non-small cell lung cancer
• Outline a multidisciplinary approach for the management of non-small cell lung cancer
• Describe the role of NCCN non-small cell lung cancer outcomes database in benchmarking quality of care.

Intended Audience:
This educational program is designed to meet the needs of oncologists, oncology nurses, pharmacists and other healthcare professionals who manage patients with cancer.

Tentative Agenda:

Accreditation:

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCCN designates this educational activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 3.8 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Pharmacists
The Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

The Postgraduate Institute for Medicine designates this continuing education activity for 3.8 contact hour(s) (0.38 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number 809-999-09-108-L01-P)

Fee Information

There is no fee for this educational activity. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 4-6 weeks.

In order to receive a statement of credit, participants will need to attend the educational activity and complete the evaluation form. Partial credit will be awarded. Statements of credit will be mailed within 4 to 6 weeks of the meeting. Pharmacists should note that they must attend a minimum of one hour to be eligible for credit. Please refer to the registration section for information regarding fees and refund policy.

This is a knowledge-based educational activity.

Faculty Disclosure

All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Program Location:
Crowne Plaza Cabaña
4290 El Camino Real
Palo Alto, California
(Directions)

Hosted By:
Stanford Comprehensive Cancer Center

Contributors:
Supported by educational grants from AstraZeneca and Abraxis BioScience, Bristol-Myers Squibb and ImClone Systems, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genentech BioOncology and OSI Oncology, Novartis Oncology, and sanofi-aventis U.S.

Registration Information:
Registration fees are:

If cancellation is necessary, please notify NCCN. A substitute attendee may be sent in your place. Registration fees are non-refundable.

Register now to secure a seat at this symposium.